• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) VOLBELLA WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) VOLBELLA WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94728JR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Foreign Body Reaction (1868); Necrosis (1971)
Event Date 02/17/2020
Event Type  Injury  
Manufacturer Narrative
A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.Clarification: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The events are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.These are known potential adverse events addressed in the product labeling.
 
Event Description
Healthcare professional (hcp) reported injecting a patient with juvéderm® voluma¿ with lidocaine and juvéderm® volbella¿ with lidocaine.The injector received a biopsy report, dated about 10 months after the injection, from the treating hcp showing a diagnosis of ¿extensive granulomatous inflammation aimed at foreign material of uncertain nature.¿ patient presented bilateral nodular lesions in the area of the prefacial lymph nodes, cheeks.Clinically necrosis was seen.Patient recovered fully with no visual lumps on skin.Patient is comfortable with the outcome.This is the same event and the same patient reported under mdr id # 3005113652-2020-00339 (allergan complaint # (b)(4)).This mdr is being submitted for the second suspect product, juvéderm® volbella¿ with lidocaine, also a device manufactured by allergan.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VOLBELLA WITH LIDOCAINE
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
michelle burgess
12331-a riata trace parkway
building 3
austin, TX 78727
7372473605
MDR Report Key10167976
MDR Text Key195571781
Report Number3005113652-2020-00340
Device Sequence Number1
Product Code LMH
Combination Product (y/n)Y
Reporter Country CodeSF
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 06/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2020
Device Catalogue Number94728JR
Device Lot NumberV15LA80602
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/22/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
JUVÉDERM® VOLUMA¿ WITH LIDOCAINE
Patient Age57 YR
-
-